Dr. Reddy's Targets Roche's Rituxan in Europe: Corporate India Businessweek Making a version of rituximab, the ingredient in cancer-treatment Rituxan, is where “the big opportunity is in the developed markets, clearly; that's where the big sales are,” he said. Dr. Reddy's joins larger rivals including Novartis AG and Pfizer ... |
